Search for Clinical Trial Results
Colitis - 241 Studies Found
Status | Study |
Completed |
Study Name: Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) Condition: Ulcerative Colitis Date: 2012-08-23 |
Recruiting |
Study Name: Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis Condition: Colitis Date: 2016-02-16 Interventions: Drug: Golimumab (GLM) GLM is a human IgG1κ monoclonal antibody produced by a murine hybridoma cell |
Completed |
Study Name: Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis Condition: Ulcerative Colitis Date: 2006-03-02 Interventions:
|
Completed |
Study Name: Rituximab in Active Ulcerative Colitis Condition: Ulcerative Colitis Date: 2005-11-29 Interventions: Drug: Rituximab Rituximab 1g in 500 mls Normal Saline Placebo 500 mls Normal Saline |
Completed |
Study Name: A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Condition: Ulcerative Colitis Date: 2009-02-27 Interventions:
|
Completed |
Study Name: Budesonide Treatment for Lymphocytic Colitis Condition: Microscopic Colitis Date: 2005-09-09 Interventions: Drug: Budesonide |
Completed |
Study Name: Basiliximab in Moderate to Severe Ulcerative Colitis Condition: Ulcerative Colitis Date: 2007-01-31 Interventions: Drug: Basiliximab 3 doses of 40mg, IV at baseline, week 2, and week 4 |
Completed |
Study Name: Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis Condition: Ulcerative Colitis Date: 2012-06-01 Interventions:
|
Completed |
Study Name: Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle Condition: Ulcerative Colitis Date: 2013-01-17 Interventions:
|
Completed |
Study Name: Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis Condition: Ulcerative Colitis Date: 2007-12-12 Interventions: Biological: adalimumab Prefilled syringes 40 mg EOW subcutaneous and prefilled syringes 40 mg weekly sub |